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S1. Formation of DNA-peptide probes
The synthetic DNA contained a disulfide modification on its 3' end that needed to be reduced prior to conjugation. Tris(2-carboxyethyl)-phosphine (TCEP) was used as the reducing agent. 20 μL of TCEP reducing beads (Thermo Fisher Scientific, IL, USA) was incubated with 100 μL of 2 μM DNA at 37°C for 2 h with vigorous shaking. The sample was then centrifuged at 1000 × g for 5 min, and the supernatant containing the reduced DNA was added to an equal volume of 20 μM maleimide-modified substrate peptide. The conjugation reaction was carried out at 37°C for 4 h with vigorous shaking, followed by immediate purification. The DNA-peptide conjugate was isolated from the excess of non-conjugated DNA and peptide by high performance liquid chromatography (HPLC). The HPLC condition was provided in the corresponding figure. Quantification was performed using external calibration peak area measurement.
S2. Biotinylation of miRNAs
Total RNA was isolated from cells and tissue homogenates using TRIzol ® Reagent and quantified using a NanoDrop spectrophotometer (Thermo Fisher Scientific Inc., MA, USA). Following the manufacturer's protocol, 100 μg of total RNA in a 30 μL reaction volume was biotinylated using Pierce TM RNA 3' End Biotinylation Kit (Thermo Fisher Scientific Inc., MA, USA). Then, 20 μL biotinylated RNA was added with an equal volume of streptavidin agarose (Life Technologies, MD, USA) and incubated at 37°C on a shaker for 2 h, followed by washing and centrifugation. Streptavidin agarose was in advance coated with RNase-free BSA and yeast tRNA to prevent non-specific binding of RNA and protein complexes. For each 100 μL of beads, 10 μL tRNA (10 mg/mL) and 10 μL BSA (10 mg/mL) were added.
S3. In-solution Tryptic Digestion S-15
The streptavidin agarose:biotinylated miRNAs:DNA-peptide complexes were mixed with 100 μL of 50 mM NH4HCO3. Subsequently, sequencing grade trypsin was added and the sample was incubated at 37°C for 24 h. The reaction was stopped by adding 10 μL of 0.1% TFA. Then, 100 μL of the internal standard solution was added to the tryptic peptide mixture before transferring it into an Oasis HLB cartridge (60 mg/3 mL; Waters, Milford, MA, USA) that was preconditioned with 3 mL ACN and 3 mL deionized water. After the sample was loaded, the cartridge was washed with 2 mL of water and 2 mL of ACN:water (50:50, v/v) 
